Houston, TX 的 前列腺癌 臨床試驗
76 項針對 前列腺癌 的研究正在 Houston（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
招募中1/2 期
- The University of Texas MD Anderson Cancer Center, Houston
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
招募中1 期
- University of Texas MD Anderson Cancer Center, Houston
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中觀察性研究歡迎健康志工
- UT MD Anderson Cancer Center, Houston
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
招募中2 期
- The University of Texas MD Anderson Cancer Center, Houston
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
招募中1 期
- MD Anderson Cancer Center, Houston
Pre-Surgical Tirzepatide-Assisted Weight Loss in Overweight and Obese Men With Intermediate Risk Prostate Cancer: A Pilot Feasibility Study
招募中早期第 1 期
- The University of Texas M. D. Anderson Cancer Center, Houston
Decision Support Tool to Enhance Germline Genetic Testing for Patients With Prostate Cancer
招募中
- M D Anderson Cancer Center, Houston
Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
招募中1/2 期
- Research Site, Houston
Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
招募中1/2 期
- MD Anderson Cancer Center, Houston
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
招募中3 期
- Texas Oncology - Gulf Coast ( Site 8002), Houston
A Study in Patients With Metastatic Castration-Resistant Prostate Cancer
招募中1 期
- NEXT Houston, Houston
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
招募中1 期
- MD Anderson Cancer Center, Houston
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
招募中3 期
- Renovatio Clinical, Houston
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
招募中3 期
- Research Site, Houston
Phase I/II Study of PEGylated Arginine Deiminase (ADI-PEG20) With Carboplatin and Cabazitaxel in Men With Aggressive Variant Prostate Cancers (AVPC)
招募中1/2 期
- MD Anderson Cancer Center, Houston
High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
招募中2 期
- Michael E. DeBakey VA Medical Center, Houston, TX, Houston
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
招募中3 期
- University of Texas-MD Anderson Cancer Center ( Site 0055), Houston
Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer
招募中1 期
- University of Texas MD Anderson Cancer Center, Houston
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
招募中3 期
- UT MD Anderson Cancer Center, Houston
- MD Anderson West Houston, Houston
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
招募中1 期
- Investigational Site Number: 401, Houston
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
招募中1 期
- UT MD Anderson, Houston
A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)
招募中3 期
- Houston Metro Urology (HMU), Houston
Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
招募中1/2 期
- Research Site, Houston
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
招募中3 期
- Research Site, Houston
A Pilot Presurgical Trial of REGN5678 (Anti-PSMA x CD28) in Patients With High-risk, Localized Prostate Cancer Followed by Radical Prostatectomy
招募中1/2 期
- M D Anderson Cancer Center, Houston
A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss
招募中2 期
- Michael E. DeBakey VA Medical Center, Houston, TX, Houston
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
招募中1 期
- University of Texas MD Anderson Cancer Center, Houston
A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
招募中1/2 期
- Oncology Consultants, P.A, Houston
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
招募中2 期
- Oncology Consultants, Houston
FOG-001 in Locally Advanced or Metastatic Solid Tumors
招募中1/2 期
- The University of Texas MD Anderson Cancer Center, Houston
Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer
招募中2 期
- U.T. MD Anderson Cancer Center, Houston
Diagnostic Performance Of Non-Endorectal Coil Multiparametric Magnetic Resonance Imaging Of Prostate With Flexible AIR Coil (DoNEMAC Study)
招募中
- The University of Texas MD Anderson Cancer Center, Houston
A Ph Ib Study of REGN5678 Plus Cemiplimab in Patients With mCRPC
招募中1 期
- The University of Texas M. D. Anderson Cancer Center, Houston
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
招募中1 期
- Houston Methodist Hospital, Houston
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
招募中1/2 期
- Research Site, Houston
Comprehensive Monitoring of Men With Prostate Cancer Cared for by "Active Surveillance
招募中觀察性研究
- M D Anderson Cancer Center, Houston
A Study of DM002 in Patients With Advanced Solid Tumors
招募中1/2 期
- The University of Texas, MD Anderson Cancer Center, Houston
IDOV-Immune for Advanced Solid Tumors
招募中1 期
- MD Anderson Cancer Center, Houston
PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.
招募中3 期
- MD Anderson Cancer Center, Houston
NeoAdjuvant Theranostic Lutetium Study: The Nautilus Trial
招募中1/2 期
- M D Anderson Cancer Center, Houston
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
招募中3 期
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
- Ben Taub General Hospital, Houston
- Houston Methodist Hospital, Houston
- 還有 4 項
Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells
招募中2 期
- UT MD Anderson Cancer Center, Houston
Stem Cells for Erectile Dysfunction Post RALP
招募中1/2 期
- Houston Methodist, Houston
Efforts to Increase Representation in Prostate Cancer Clinical Trials at Lyndon B. Johnson Hospital
招募中
- The University of Texas M. D. Anderson Cancer Center, Houston
Androgen Ablation Therapy With or Without Niraparib After Radiation Therapy for the Treatment of High-Risk Localized or Locally Advanced Prostate Cancer
招募中2 期
- M D Anderson Cancer Center, Houston
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
招募中2 期
- Michael E. DeBakey VA Medical Center, Houston
Presurgical Phase II Study of Talazoparib in Combination With Enzalutamide in Prostate Cancer
招募中2 期
- M D Anderson Cancer Center, Houston
A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer
招募中1/2 期
- Next Oncology - Houston, Houston
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
招募中4 期
- UT Health Science Center, Houston
An Evidence-Based Focal Cryotherapy Protocol for Focal Ablation of Intermediate Risk Prostate Cancer
招募中2 期
- MD Anderson Cancer Center, Houston
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
招募中1/2 期
- MD Anderson Cancer Center, Houston
Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Cognitive and Usability Testing
招募中觀察性研究
- M D Anderson Cancer Center, Houston
Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial
招募中
- M D Anderson Cancer Center, Houston
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
招募中2/3 期
- Michael E. DeBakey VA Medical Center, Houston, TX, Houston
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
招募中1/2 期
- MD Anderson Cancer Center, Houston
Neoadjuvant High Dose Rate Brachytherapy Prior to Radical Prostatectomy in Patients With Prostate Cancer
招募中1/2 期
- Houston Methodist, Houston
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
招募中觀察性研究
- Md Anderson Cancer Center, Houston
Study of AZD0754 in Participants With Metastatic Prostate Cancer
招募中1/2 期
- Research Site, Houston
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
招募中1 期
- MD Anderson Cancer Center, Houston
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
招募中1 期
- Houston Metro Urology, Houston
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
招募中3 期
- Lyndon Baines Johnson General Hospital, Houston
- M D Anderson Cancer Center, Houston
- MD Anderson West Houston, Houston
A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors
招募中1 期
- Oncology Consultants, Houston
Evaluation of Response to Abiraterone/Prednisone by Race/Ethnicity and Other Factors in Metastatic Hormone Naive Prostate Cancer
招募中2 期
- Ben Taub General Hospital, Houston
- Dan L. Duncan Comprehensive Cancer Center at Baylor College of Medicine, Houston
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
招募中1/2 期
- The University of Texas MD Anderson Cancer Center, Houston
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中觀察性研究
- Massive Bio SYNERGY-AI site, Houston
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
招募中3 期
- Lyndon Baines Johnson General Hospital, Houston
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
- Ben Taub General Hospital, Houston
- 還有 3 項
Comprehensive Assessment of Cancer Theranostic Response
招募中
- M.D. Anderson Cancer Center, Houston
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
招募中1 期
- Exelixis Clinical Site #1, Houston
Treatment of Patients With Progressive mCRPC With 177Lu-PSMA-617
招募中2 期
- Excel Diagnostics & Nuclear Oncology Center, Houston
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
招募中1/2 期
- The University of Texas MD Anderson Cancer Center, Houston
Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Efficacy Testing
招募中觀察性研究
- M.D. Anderson Cancer Center, Houston
A Study of Evofosfamide in Combination with Zalifrelimab and Balstilimab
招募中1/2 期
- MD Anderson Cancer Center, Houston
Comprehensive Outcomes for After Cancer Health
招募中歡迎健康志工
- The University of Texas MD Anderson Cancer Center, Houston
- UT Health Houston, Houston
Modifying Metabolic Syndrome and Cardiovascular Risk for Prostate Cancer Patients on ADT Using a Risk Factor Modification Program and Continuous Fitbit Monitoring
招募中2 期
- M D Anderson Cancer Center, Houston
Phase II High Risk Prostate Cancer Trial Using Gene & Androgen Deprivation Therapies, Radiotherapy, & Surgery
招募中2 期
- Houston Methodist Hospital, Houston
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
招募中1/2 期
- Houston Methodist, Houston
其他城市的 前列腺癌 試驗
- New York City, NY103 項研究
- Los Angeles, CA61 項研究
- Boston, MA59 項研究
- St. Louis, MO46 項研究
- Chicago, IL45 項研究
- San Francisco, CA45 項研究
- Philadelphia, PA44 項研究
- Baltimore, MD43 項研究
- Nashville, TN42 項研究
- Seattle, WA42 項研究
- Washington, DC38 項研究
- Dallas, TX36 項研究
Houston 的其他研究
- 非小細胞肺癌145 項研究
- 乳癌126 項研究
- 癌症（所有類型）121 項研究
- 轉移性癌症104 項研究
- 大腸直腸癌102 項研究
- 卵巢癌89 項研究
- 急性髓系白血病85 項研究
- 肺癌78 項研究
- 子宮內膜癌68 項研究
- 胰臟癌61 項研究
- 黑色素瘤59 項研究
- 頭頸部鱗狀細胞癌47 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月5日。各研究自行設定資格標準；由研究團隊決定參與者資格。